Juyeon Hong et al., 2024-05: Study reporting that mebendazole acts preferentially on primary cilia rather than cytosolic microtubules, and that ciliated cancer cells are more sensitive to mebendazole plus conventional drugs.
Here, using Xenopus laevis embryos as a model system, we discovered that MBZ significantly hinders cilia formation and induces DNA damage.
Juyeon Hong et al., 2024-05: Study reporting that mebendazole acts preferentially on primary cilia rather than cytosolic microtubules, and that ciliated cancer cells are more sensitive to mebendazole plus conventional drugs. Study type: Xenopus embryo model plus cancer cell lines. N: not applicable. Country: South Korea (UNIST, Ulsan). Dose: not stated in the abstract text captured. Funder: not stated in the record. Declared conflicts: 'The authors declare that they have no competing interest.' PARTLY because it attributes anticancer activity to a cilium-specific effect rather than to mitotic-spindle disruption, which qualifies the C2 mechanism as stated. Study type: lab.
